Global Meningococcal Conjugate Market Insights, Forecast to 2029

Global Meningococcal Conjugate Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by End User
1.3.1 Global Meningococcal Conjugate Market Size Growth Rate by End User, 2018 VS 2022 VS 2029
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2018-2029)
2.2 Global Meningococcal Conjugate Growth Trends by Region
2.2.1 Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Meningococcal Conjugate Historic Market Size by Region (2018-2023)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Region (2024-2029)
2.3 Meningococcal Conjugate Market Dynamics
2.3.1 Meningococcal Conjugate Industry Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Meningococcal Conjugate by Players
3.1.1 Global Meningococcal Conjugate Revenue by Players (2018-2023)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2018-2023)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Meningococcal Conjugate, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2022
3.5 Global Key Players of Meningococcal Conjugate Head office and Area Served
3.6 Global Key Players of Meningococcal Conjugate, Product and Application
3.7 Global Key Players of Meningococcal Conjugate, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2018-2023)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029)
5 Meningococcal Conjugate Breakdown Data by End User
5.1 Global Meningococcal Conjugate Historic Market Size by End User (2018-2023)
5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2018-2029)
6.2 North America Meningococcal Conjugate Market Size by Type
6.2.1 North America Meningococcal Conjugate Market Size by Type (2018-2023)
6.2.2 North America Meningococcal Conjugate Market Size by Type (2024-2029)
6.2.3 North America Meningococcal Conjugate Market Share by Type (2018-2029)
6.3 North America Meningococcal Conjugate Market Size by End User
6.3.1 North America Meningococcal Conjugate Market Size by End User (2018-2023)
6.3.2 North America Meningococcal Conjugate Market Size by End User (2024-2029)
6.3.3 North America Meningococcal Conjugate Market Share by End User (2018-2029)
6.4 North America Meningococcal Conjugate Market Size by Country
6.4.1 North America Meningococcal Conjugate Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Meningococcal Conjugate Market Size by Country (2018-2023)
6.4.3 North America Meningococcal Conjugate Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2018-2029)
7.2 Europe Meningococcal Conjugate Market Size by Type
7.2.1 Europe Meningococcal Conjugate Market Size by Type (2018-2023)
7.2.2 Europe Meningococcal Conjugate Market Size by Type (2024-2029)
7.2.3 Europe Meningococcal Conjugate Market Share by Type (2018-2029)
7.3 Europe Meningococcal Conjugate Market Size by End User
7.3.1 Europe Meningococcal Conjugate Market Size by End User (2018-2023)
7.3.2 Europe Meningococcal Conjugate Market Size by End User (2024-2029)
7.3.3 Europe Meningococcal Conjugate Market Share by End User (2018-2029)
7.4 Europe Meningococcal Conjugate Market Size by Country
7.4.1 Europe Meningococcal Conjugate Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Meningococcal Conjugate Market Size by Country (2018-2023)
7.4.3 Europe Meningococcal Conjugate Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Meningococcal Conjugate Market Size (2018-2029)
8.2 China Meningococcal Conjugate Market Size by Type
8.2.1 China Meningococcal Conjugate Market Size by Type (2018-2023)
8.2.2 China Meningococcal Conjugate Market Size by Type (2024-2029)
8.2.3 China Meningococcal Conjugate Market Share by Type (2018-2029)
8.3 China Meningococcal Conjugate Market Size by End User
8.3.1 China Meningococcal Conjugate Market Size by End User (2018-2023)
8.3.2 China Meningococcal Conjugate Market Size by End User (2024-2029)
8.3.3 China Meningococcal Conjugate Market Share by End User (2018-2029)
9 Asia (excluding China)
9.1 Asia Meningococcal Conjugate Market Size (2018-2029)
9.2 Asia Meningococcal Conjugate Market Size by Type
9.2.1 Asia Meningococcal Conjugate Market Size by Type (2018-2023)
9.2.2 Asia Meningococcal Conjugate Market Size by Type (2024-2029)
9.2.3 Asia Meningococcal Conjugate Market Share by Type (2018-2029)
9.3 Asia Meningococcal Conjugate Market Size by End User
9.3.1 Asia Meningococcal Conjugate Market Size by End User (2018-2023)
9.3.2 Asia Meningococcal Conjugate Market Size by End User (2024-2029)
9.3.3 Asia Meningococcal Conjugate Market Share by End User (2018-2029)
9.4 Asia Meningococcal Conjugate Market Size by Region
9.4.1 Asia Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Meningococcal Conjugate Market Size by Region (2018-2023)
9.4.3 Asia Meningococcal Conjugate Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type
10.2.1 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User
10.3.1 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2018-2023)
10.3.2 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2024-2029)
10.3.3 Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by End User (2018-2029)
10.4 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country
10.4.1 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Details
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023)
11.1.5 Sanofi Pasteur Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2018-2023)
11.2.5 Pfizer Recent Developments
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Details
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023)
11.3.5 Glaxo Smith Kline Recent Developments
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Details
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023)
11.4.5 Hualan Biological Engineering Recent Developments
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Details
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023)
11.5.5 JN International Medical Corporation Recent Developments
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2018-2023)
11.6.5 Baxter International Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2018-2023)
11.7.5 Merck Recent Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Details
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023)
11.8.5 Serum Institute of India Recent Developments
11.9 Biomed
11.9.1 Biomed Company Details
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2018-2023)
11.9.5 Biomed Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2018-2023)
11.10.5 Novartis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth Rate by End User (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Meningococcal Conjugate Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Region (2018-2023)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Region (2024-2029)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Meningococcal Conjugate Revenue Share by Players (2018-2023)
Table 19. Global Top Meningococcal Conjugate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Table 20. Global Meningococcal Conjugate Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Meningococcal Conjugate, Headquarters and Area Served
Table 23. Global Key Players of Meningococcal Conjugate, Product and Application
Table 24. Global Key Players of Meningococcal Conjugate, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2018-2023)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2024-2029)
Table 30. Global Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Share by End User (2018-2023)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2029) & (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Share by End User (2024-2029)
Table 34. North America Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Meningococcal Conjugate Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 37. North America Meningococcal Conjugate Market Size by End User (2024-2029) & (US$ Million)
Table 38. North America Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Meningococcal Conjugate Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 44. Europe Meningococcal Conjugate Market Size by End User (2024-2029) & (US$ Million)
Table 45. Europe Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Meningococcal Conjugate Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 51. China Meningococcal Conjugate Market Size by End User (2024-2029) & (US$ Million)
Table 52. Asia Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Meningococcal Conjugate Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 55. Asia Meningococcal Conjugate Market Size by End User (2024-2029) & (US$ Million)
Table 56. Asia Meningococcal Conjugate Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Meningococcal Conjugate Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by End User (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Meningococcal Conjugate Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size by Country (2024-2029) & (US$ Million)
Table 66. Sanofi Pasteur Company Details
Table 67. Sanofi Pasteur Business Overview
Table 68. Sanofi Pasteur Meningococcal Conjugate Product
Table 69. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 70. Sanofi Pasteur Recent Developments
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Meningococcal Conjugate Product
Table 74. Pfizer Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Developments
Table 76. Glaxo Smith Kline Company Details
Table 77. Glaxo Smith Kline Business Overview
Table 78. Glaxo Smith Kline Meningococcal Conjugate Product
Table 79. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 80. Glaxo Smith Kline Recent Developments
Table 81. Hualan Biological Engineering Company Details
Table 82. Hualan Biological Engineering Business Overview
Table 83. Hualan Biological Engineering Meningococcal Conjugate Product
Table 84. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 85. Hualan Biological Engineering Recent Developments
Table 86. JN International Medical Corporation Company Details
Table 87. JN International Medical Corporation Business Overview
Table 88. JN International Medical Corporation Meningococcal Conjugate Product
Table 89. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 90. JN International Medical Corporation Recent Developments
Table 91. Baxter International Company Details
Table 92. Baxter International Business Overview
Table 93. Baxter International Meningococcal Conjugate Product
Table 94. Baxter International Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 95. Baxter International Recent Developments
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Meningococcal Conjugate Product
Table 99. Merck Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 100. Merck Recent Developments
Table 101. Serum Institute of India Company Details
Table 102. Serum Institute of India Business Overview
Table 103. Serum Institute of India Meningococcal Conjugate Product
Table 104. Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 105. Serum Institute of India Recent Developments
Table 106. Biomed Company Details
Table 107. Biomed Business Overview
Table 108. Biomed Meningococcal Conjugate Product
Table 109. Biomed Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 110. Biomed Recent Developments
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Meningococcal Conjugate Product
Table 114. Novartis Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 115. Novartis Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Meningococcal Conjugate Market Share by Type: 2022 VS 2029
Figure 3. Menactra Features
Figure 4. Menveo Features
Figure 5. NeisVac-C Features
Figure 6. Nimenrix Features
Figure 7. Others Features
Figure 8. Global Meningococcal Conjugate Market Size Growth Rate by End User, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Meningococcal Conjugate Market Share by End User: 2022 VS 2029
Figure 10. Children Case Studies
Figure 11. Preteens or Teens Case Studies
Figure 12. Adults Case Studies
Figure 13. Meningococcal Conjugate Report Years Considered
Figure 14. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Meningococcal Conjugate Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Meningococcal Conjugate Market Share by Region: 2022 VS 2029
Figure 17. Global Meningococcal Conjugate Market Share by Players in 2022
Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2022
Figure 20. North America Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Meningococcal Conjugate Market Share by Type (2018-2029)
Figure 22. North America Meningococcal Conjugate Market Share by End User (2018-2029)
Figure 23. North America Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 24. United States Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Meningococcal Conjugate Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Meningococcal Conjugate Market Share by Type (2018-2029)
Figure 28. Europe Meningococcal Conjugate Market Share by End User (2018-2029)
Figure 29. Europe Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 30. Germany Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Meningococcal Conjugate Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Meningococcal Conjugate Market Share by Type (2018-2029)
Figure 38. China Meningococcal Conjugate Market Share by End User (2018-2029)
Figure 39. Asia Meningococcal Conjugate Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Meningococcal Conjugate Market Share by Type (2018-2029)
Figure 41. Asia Meningococcal Conjugate Market Share by End User (2018-2029)
Figure 42. Asia Meningococcal Conjugate Market Share by Region (2018-2029)
Figure 43. Japan Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Meningococcal Conjugate Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by End User (2018-2029)
Figure 52. Middle East, Africa, and Latin America Meningococcal Conjugate Market Share by Country (2018-2029)
Figure 53. Brazil Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Meningococcal Conjugate Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 61. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 62. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 63. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 64. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 65. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 66. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 67. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 68. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs